JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.43, ss.1708-1713, 2017 (SCI İndekslerine Giren Dergi)
AimFingolimod is a sphingosine-1-phosphate receptor modulator used for multiple sclerosis treatment and acts on cellular processes such as apoptosis, endothelial permeability, and inflammation. We hypothesized that fingolimod has a positive effect on alleviating preterm fetal brain injury.